Ticker delayed 20 minutes
Avg Daily Volume: 1,175,032 Market Cap: 3.66B Sector: Technology Short Interest: 8.58 |
EARNINGS EXPECTATIONS:
THIS QTR: EPS: .35/share REV: 85.3/M
___________________________________________________________
LAST QTR: EPS: .33/share ACTUAL: .41/share (BEAT)
____________________________________________________________
NEXT QTR: EPS: .31/share REV: 83.9/M
______________________________________________________
FULL YR: EPS: 1.33/share REV: 343.3/M
______________________________________________________
*These are the base metrics we will be watching against the actual release numbers
______________________________________________________
BEAT/MISS RECORD: 91% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) 4.89, -4.06, -13.75
POTENTIAL JUMP MOVE: 8-10%
Links To Latest News and Headlines
HealthEquity (HQY) reported earnings 30 days ago. What’s next for the stock? We take a look at earnings estimates for some clues.
HealthEquity Inc (NASDAQ: HQY) has agreed to acquire Further, a health savings account provider (HSA) and consumer-directed benefit administration services for $500 million. The acquisition of Further and its technology reinforces HealthEquity’s position in the HSA market and other go-to-market partners. With Further’s approximately 550,000 HSA customers and $1.7 billion HSA assets under its custody, HealthEquity will grow to about 6.3 million HSA Members and more than $16 billion in HSA Assets. The acquisition also immediately expands HealthEquity’s health plan footprint, particularly its commitment to not-for-profit health plans. Further also brings approximately 28,000 employer clients and over 300,000 consumer-directed benefit accounts (CDBs). At closing, management expects the transaction to add approximately $60 million in revenue on an annualized run-rate basis, with a 20% contribution to the adjusted EBITDA margin. Management expects to achieve an additional $15 million in efficiencies on an annualized basis within three years, with $55 million of one-time costs incurred over that period. The transaction is expected to close by September. Price Action: HQY shares closed 1.9% higher at $67.55 on Thursday. See more from BenzingaClick here for options trades from BenzingaHumanigen’s Ifabotuzumab Shows Encouraging Action In Early-Stage Brain Cancer StudyAffimed Stock Jumps After Natural Killer Cells With AFM13 Show Clinical Responses, Minimal Toxicity© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Technology-enabled services platforms provider HealthEquity has agreed to acquire Further for a consideration of $500 million. The latter provides health savings account (HSA) and consumer direct benefit administration services. HealthEquity (HQY) President and CEO, Jon Kessler said, “By putting HealthEquity’s Total Solution inside of network partner applications and private-label brand environments, Further’s technology will align us more closely than ever before and enable new partnerships to introduce more consumers to HSAs.” This acquisition helps HealthEquity expand its leadership in the HSA market and enhance its ability to achieve higher growth with health plans and other go-to-market partners. (See HealthEquity stock analysis on TipRanks) Further has about 550 thousand HSA customers and $1.7 billion HSA assets under custody. This increases HealthEquity’s HSA members to 6.3 million and HSA assets to more than $16 billion. HealthEquity estimates this acquisition to add about $60 million in annual revenue and 20% contribution to adjusted EBITDA margin. It also sees additional annual efficiencies of $15 million within three years, with $55 million in one-time expenses incurred over the same period. The transaction is expected to close by September. On April 5, Leerink Partners analyst Stephanie Davis reiterated a Hold rating on the stock with a $80 price target (18.4% upside potential). Davis commented, “HQY remains a dominant HSA/CDB player, benefitting from employers’ growing preference for one stop shops for employee directed benefits.” Overall, consensus among analysts is that HealthEquity is a Moderate Buy based on 5 Buys and 2 Holds. The average analyst price target of $87.43 implies upside potential of 29.4%. Shares have gained about 32.8% over the past year. Related News: Best Buy Launches $200 Per Year Membership Program Okta Reaffirms Financial Outlook, Launches New Products On Investor Day Shell Expects To Take A $200M Hit From Texas Winter Storm More recent articles from Smarter Analyst: Canopy Growth Snaps Up Supreme Cannabis For $435 Million Syndax Pharma’s Axatilimab Receives Orphan Drug Designation For Treatment Of Chronic Lung Disease KemPharm Amends AZSTARYS Licensing Agreement With Gurnet Point Capital Affiliate Levi’s 1Q Sales And EPS Beat Estimates; Street Says Buy
Adds private-label capabilities, significant health plan relationships and VEBA solutionsDRAPER, Utah, April 08, 2021 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity”), the nation’s largest independent health savings account (“HSA”) custodian, today announced that it had entered into a definitive agreement to acquire Further, a leading provider of HSA and consumer directed benefit administration services, and the nation’s ninth largest HSA custodian overall. The acquisition of Further and its technology expands HealthEquity’s leadership in the growing HSA market, enhances its ability to drive growth with health plans and other go-to-market partners, and adds to its Total Solution offering of remarkable products backed by trademark Purple service, education and engagement to help working families connect health and wealth. Expanded HSA Leadership With Further’s approximately 550,000 HSA customers and $1.7 billion HSA assets under its custody, HealthEquity will grow to approximately 6.3 million HSA Members and more than $16 billion in HSA Assets, adding to its position as the leading health savings custodian nationwide. The acquisition also immediately expands HealthEquity’s health plan footprint, particularly its commitment to not-for-profit health plans. Further also brings approximately 28,000 employer clients and over 300,000 consumer-directed benefit accounts (CDBs), including FSAs, HRAs and VEBAs. Technology-Driven Partner Growth Further’s private-label HSA and CDB solutions, deployed in the cloud, expand HealthEquity’s reach to a growing network of health plan, retirement plan, benefits administration, and other go-to-market partners. “By putting HealthEquity’s Total Solution inside of network partner applications and private-label brand environments, Further’s technology will align us more closely than ever before and enable new partnerships to introduce more consumers to HSAs,” said President and CEO Jon Kessler. New VEBA Administration Capability Further is also a technology leader in employer-funded Voluntary Employees’ Beneficiary Association (VEBA) trust administration. VEBAs are triple-tax advantaged health accounts like HSAs, that cover medical costs while employed or post-retirement. VEBAs are not restricted to those in high-deductible health plans. “Adding VEBA capability to HealthEquity’s Total Solution brings a new choice to clients and partners seeking to offer differentiated benefits while controlling healthcare costs,” added Kessler. A Legacy of Care Further is part of Stella Health, a Minnesota-based family of companies committed to reinventing health care to improve health for the people it serves. In addition to Further, the Stella family includes Minnesota’s largest non-profit health plan; supportive medical care services; and a number of other subsidiary and affiliate companies. “For more than thirty years, Further has been helping people seamlessly manage their money, health and life,” said Jay Matushak, senior vice president and CFO of Stella. “We know our partners, employers, members and associates will be in great hands with HealthEquity. Their commitment to innovation, customer service and value is well-known and highly regarded within the HSA industry. With Stella placing a greater strategic emphasis on developing new care delivery models, HealthEquity was the ideal company to carry on Further’s legacy of helping people spend and save wisely on their health care.” Financial Details HealthEquity is purchasing Further for $500 million. At closing, management expects the transaction to add approximately $60 million in revenue on an annualized run-rate basis, with a 20% contribution to adjusted EBITDA margin. Management expects to achieve an additional $15 million in efficiencies on an annualized basis within three years, with $55 million of one-time costs incurred over that time period. The transaction is subject to regulatory approvals and other customary closing conditions and is expected to close by September 2021. Kessler continued, “We look forward to welcoming the talented Further family to our Purple culture, and to working together to deliver remarkable results to our members, clients, partners and expanded team.” Advisors Willkie Farr & Gallagher LLP is serving as legal counsel and Perella Weinberg Partners LP is serving as exclusive financial advisor to HealthEquity. Stella has engaged Taft Stettinius & Hollister LLP for legal counsel and Wells Fargo Securities as exclusive financial advisor. About HealthEquity HealthEquity and its subsidiaries administers Health Savings Accounts (HSAs) and other consumer-directed benefits for our more than 12 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who share our mission to connect health and wealth and value our culture of remarkable “Purple” service. For more information, visit www.healthequity.com. About Further Headquartered in Eagan, Minn., Further provides health savings accounts (HSAs), flexible spending accounts, (FSAs), health reimbursement arrangements (HRAs), voluntary employee beneficiary association (VEBA) accounts and commuter benefit and custodian services. Serving large corporations, small businesses, labor unions, retirees, and groups in the public sector, Further guides account holders across the United States in saving and spending wisely on their health care. Further is an IRS-approved nonbank trustee through the U.S. Department of Treasury. For more information, visit: www.hellofurther.com Forward-looking statements This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release. Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following: the impact of the COVID-19 pandemic on the Company, its operations and its financial results;our ability to realize the anticipated financial and other benefits from combining the operations of Further with our business in an efficient and effective manner;our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry;our dependence on the continued availability and benefits of tax-advantaged health savings accounts and other consumer-directed benefits;our ability to realize the anticipated financial and other benefits to the Company from acquiring Further;our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets;the significant competition we face and may face in the future, including from those with greater resources than us;our reliance on the availability and performance of our technology and communications systems;recent and potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business;the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations;our ability to comply with current and future privacy, healthcare, tax, investment advisor and other laws applicable to our business;our reliance on partners and third-party vendors for distribution and important services;our ability to develop and implement updated features for our technology and communications systems and successfully manage our growth;our ability to protect our brand and other intellectual property rights; andour reliance on our management team and key team members. For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our most recent Annual Report on Form 10-K and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release. Investor Relations Contact: Media Relations Contact:Richard Putnam Amy Cerny801-727-1209801-508-3237rputnam@healthequity.com acerny@healthequity.com Stella Health Contact: Jim McManus 651-662-2882 media@stellahealth.com
APT, HQY and MFIN have been added to the Zacks Rank #5 (Strong Sell) List on March 19, 2021
StockJumpers analysis and trade plans are uploaded generally 1 HOUR (3PM EST) for most events.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is striped down to only what it needed to make the best possible decision(s) on trading the trajectory.
NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.